Alnylam Pharmaceuticals (0HD2.L) Stock Price
$450.6 2.2%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
6 -
Technical
5
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Alnylam Pharmaceuticals, AI stock picks, stock alerts and much more.
0HD2.L AI Stock Analysis
AI stock analysis for 0HD2.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Alnylam Pharmaceuticals (0HD2.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Alnylam Pharmaceuticals (0HD2.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Alnylam Pharmaceuticals (0HD2.L), currently trading at $450.6, will... Sign up to access price prediction.
About 0HD2.L
-
Alnylam Pharmaceuticals, Inc.
-
Symbol
0HD2.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
59.1B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$388.2 1.1% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$144.8 1.4% |
6 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$7.92 0.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.71 1.6% |
4 |
 |
Esperion Therapeutics 0IIM.L |
$2.75 0.2% |
6 |
News
0HD2.L Alternative Data
Web Traffic
Alnylam Pharmaceuticals receives an estimated 65439 monthly visitors to alnylam.com.
-
Web Traffic
65439
-
Change from Previous Month
16.8%
-
3 Month Change
19.9%
-
YoY Change
19.9%
Twitter Followers
Alnylam Pharmaceuticals has 17,228 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.
-
Twitter Followers
17228
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Facebook Engagement
Alnylam Pharmaceuticals has engaged 54 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
54
-
Daily Change
125%
-
1 Month Change
56.8%
-
3 Month Change
81.9%
-
YoY Change
81.9%
Instagram Followers
Alnylam Pharmaceuticals has 2,180 Instagram Followers on its main Instagram account, up by 2.6% over the last month.
-
Instagram Followers
2180
-
Daily Change
0.1%
-
1 Month Change
2.6%
-
3 Month Change
7.4%
-
YoY Change
7.4%
Youtube Subscribers
Alnylam Pharmaceuticals has 2,730 subscribers on its main Youtube channel, up by 0.4% over the last month.
-
Youtube Subscribers
2730
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
2.2%
-
YoY Change
2.2%
Job Postings
Alnylam Pharmaceuticals currenly has an estimated 172 open job postings, up by 50.9% over the last month.
-
Job Postings
172
-
Daily Change
3%
-
1 Month Change
50.9%
-
3 Month Change
79.2%
-
YoY Change
79.2%
Reddit Mentions
Alnylam Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
248,358 are following Alnylam Pharmaceuticals on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
248358
-
Daily Change
1.6%
-
1 Month Change
1.6%
-
3 Month Change
4.8%
-
YoY Change
4.8%
LinkedIn Employees
According to LinkedIn, Alnylam Pharmaceuticals has 2,613 employees, up by 0.7% over the last month.
-
LinkedIn Employees
2613
-
Daily Change
0.7%
-
1 Month Change
0.7%
-
3 Month Change
2.4%
-
YoY Change
2.4%
Business Outlook
According to employee reviews, the business outlook among employees at Alnylam Pharmaceuticals is 78 out of 100 (bullish).
-
Business Outlook
78
-
Change from Previous Month
2.6%
-
3 Month Change
1.3%
-
YoY Change
1.3%
News Mentions
Alnylam Pharmaceuticals was mentioned 3 times in the news yesterday.
-
News Mentions
3
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0HD2.L Financials
0HD2.L Key Metrics
-
Total Revenue
$593.2M
-
Net Income
-$83.8M
-
Earnings per Share
-$0.65
-
Free cash flow
-$103.8M
-
EBITDA
-$140.8M
-
EBITDA Ratio
-0.237402
-
Total Assets
$4.3B
0HD2.L 2-year Revenue & Income
0HD2.L 2-year Free Cash Flow
0HD2.L Technicals
0HD2.L SMA
0HD2.L RSI
FAQ
What's the current price of Alnylam Pharmaceuticals (0HD2.L) Stock?
The price of an Alnylam Pharmaceuticals (0HD2.L) share is $450.6.
What's the market cap of Alnylam Pharmaceuticals?
The current market cap of Alnylam Pharmaceuticals is 59.1B.
What are some stocks similar to Alnylam Pharmaceuticals (0HD2.L) that investors often compare it to?
Alnylam Pharmaceuticals (0HD2.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Alnylam Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Alnylam Pharmaceuticals' stock price to be around $492.6 in 2026. Starting from the current price of $450.6, this represents a 9.3% change in price, indicating a bullish outlook for the stock.
How to buy Alnylam Pharmaceuticals (0HD2.L) Stock?
Alnylam Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Alnylam Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.